Repligen Corporation to Present at Upcoming March Conferences

Repligen (NASDAQ:RGEN) will participate in three investor conferences in March 2026: Leerink Global Healthcare (Mar 8–11), Barclays Global Healthcare (Mar 10–12) and KeyBanc Virtual Healthcare Forum (Mar 17–18).

Rhea-AI Summary

Repligen (NASDAQ:RGEN) will participate in three investor conferences in March 2026: Leerink Global Healthcare (Mar 8–11), Barclays Global Healthcare (Mar 10–12) and KeyBanc Virtual Healthcare Forum (Mar 17–18). Executives Jason Garland and Olivier Loeillot will take part in analyst-led discussions on March 10–11 and March 18, with live webcasts for Leerink and KeyBanc available on the company investor relations website and replayable for a limited time.

Argus Mar 5 session

-0.64% close to close Open Argus

Details

News Market Reaction – RGEN

In the Mar 5 session, RGEN declined 0.64%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement highlights Repligen’s participation in three March 2026 healthcare investor confer...

Analysis

This announcement highlights Repligen’s participation in three March 2026 healthcare investor conferences, with both the CFO and CEO presenting and webcasts available via the investor relations site. It follows recent earnings, product, and governance updates that produced generally modest price moves and occasional divergences from positive fundamentals. Investors may focus on management’s commentary at these events, particularly around growth drivers, integration of recent acquisitions, and progress versus the company’s 2026 financial guidance.

Key Figures

Investor conferences: 3 conferences Leerink conference dates: March 8–11, 2026 Barclays conference dates: March 10–12, 2026 +5 more

Investor conferences

3 conferences

March 2026 investor conference participation

Leerink conference dates

March 8–11, 2026

Leerink Global Healthcare Conference in Miami

Barclays conference dates

March 10–12, 2026

Barclays 28th Annual Global Healthcare Conference in Miami

KeyBanc forum dates

March 17–18, 2026

2026 KeyBanc Virtual Healthcare Forum

Leerink presentation time

11:20 a.m. ET

CFO discussion on Tuesday, March 10, 2026

Barclays presentation time

10:30 a.m. ET

CFO discussion on Wednesday, March 11, 2026

KeyBanc presentation time

2:15 p.m. ET

CEO discussion on Wednesday, March 18, 2026

Barclays conference edition

28th Annual

Barclays Global Healthcare Conference

Historical Context

5 past events · Latest: Feb 24

5 events

1. Feb 24

   Earnings and guidance

   24h Move

   -0.5%

   Q4 and full-year 2025 beat with upbeat 2026 revenue and margin guidance.

2. Feb 10

   Earnings date set

   24h Move

   -0.4%

   Announcement of date and time for Q4 and full-year 2025 results call.

3. Jan 06

   Board leadership change

   24h Move

   +1.7%

   Executive chair retirement with experienced director elected as new board chair.

4. Dec 18

   Conference presentation

   24h Move

   +0.5%

   Participation and company overview at J.P. Morgan 2026 Healthcare Conference.

5. Dec 16

   Product launch

   24h Move

   -1.6%

   Launch of three next‑generation chromatography resins for gene therapy workflows.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., March 05, 2026 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating in three upcoming investor conferences.

• The Leerink Global Healthcare Conference, being held March 8 – 11 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 11:20 a.m. ET on Tuesday, March 10, 2026.
• The Barclays 28th Annual Global Healthcare Conference, being held March 10 – 12 in Miami. Jason Garland, Chief Financial Officer, will participate in an analyst led discussion at 10:30 a.m. ET on Wednesday, March 11, 2026.
• The 2026 KeyBanc Virtual Healthcare Forum, being held March 17 – 18. Olivier Loeillot, President and Chief Executive Officer, will participate in an analyst led discussion at 2:15 p.m. ET on Wednesday, March 18, 2026.

A live webcast of the Leerink and KeyBanc presentations will be accessible through Repligen’s Investor Relations website at www.repligen.com, and will be available for replay for a limited period of time following the events.

About Repligen Corporation
Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs. We are “inspiring advances in bioprocessing” for the customers we serve; primarily biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Our focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Our corporate headquarters are located in Waltham, Massachusetts, and the majority of our manufacturing sites are in the U.S., with additional key sites in Estonia, France, Germany, Ireland, the Netherlands and Sweden. For more information about the company see our website at www.repligen.com, and follow us on LinkedIn.

Repligen Contact:
Jacob Johnson
VP, Investor Relations
781-419-0204
investors@repligen.com

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Repligen (RGEN) present at the Leerink Global Healthcare Conference in March 2026?

Repligen will present at Leerink during March 8–11, 2026, with CFO Jason Garland speaking March 10 at 11:20 a.m. ET. According to Repligen, the presentation will be webcast and available for limited-time replay on the investor relations website.

What time is Repligen (RGEN) scheduled to speak at the Barclays Global Healthcare Conference on March 11, 2026?

Repligen's CFO Jason Garland is scheduled for an analyst discussion at Barclays on March 11, 2026 at 10:30 a.m. ET. According to Repligen, the Barclays session is part of the March 10–12 conference in Miami.

Will Repligen (RGEN) provide a webcast of its March 2026 conference presentations?

Yes, Repligen will webcast the Leerink and KeyBanc presentations and offer replay for a limited time. According to Repligen, webcasts will be accessible via the company investor relations website at www.repligen.com.

Who from Repligen (RGEN) will speak at the 2026 KeyBanc Virtual Healthcare Forum and when?

Repligen CEO Olivier Loeillot will participate in an analyst discussion at KeyBanc on March 18, 2026 at 2:15 p.m. ET. According to Repligen, the KeyBanc forum runs March 17–18 and the session will be available via webcast.

How can investors access Repligen's (RGEN) conference replays after the March 2026 events?

Investors can access replay via Repligen's investor relations website for a limited period following the events. According to Repligen, both Leerink and KeyBanc presentations will be archived briefly for on-demand viewing.

Which Repligen (RGEN) executives are speaking at the March 2026 investor conferences?

CFO Jason Garland and CEO Olivier Loeillot are scheduled to speak at the March 2026 conferences. According to Repligen, Garland will appear at Leerink and Barclays, and Loeillot will appear at the KeyBanc Virtual Healthcare Forum.